drugset / Trial / NCT01948024
Bio-equivalence Study Between SAPHRIS and Asenapine
RandomizedCrossoverOpen-labelOther
Summary
This is a Multiple-dose, steady state, three-way reference-replicated crossover study. The purpose of this Study is to determine the bio-equivalence between SAPHRIS and Asenapine 10mg sublingual tablets.
Timeline
- Start
- 2013-07
- Primary completion
- 2013-08
- Completion
- 2013-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Asenapine | Other / unclassified | 10 mg | Other |